Page 57 - 2019食藥署年報(英文版)
P. 57

To cooperate with the government's promotion of the New Southbound Policy and
                     globalization strategies and effectively enhance the consistency between Taiwan’s regulatory
                     standards and the global regulatory standards, TFDA hopes to deepen the cooperative
                     relationship with the New Southbound countries by inventorying the drug management policies
                     and information of the pharmaceutical industry in each of the new southbound countries and
                     through exchanges and learning in drug regulatory framework, to expand the overseas market
                     and export business for the industry.



                     *N
                     *NQMFNFOUBUJPO .FBTVSFTQMFNFOUBUJPO .FBTVSFT
                        4JHO UIF DPMMBCPSBUJPO EPDVNFOU GPS QIBSNBDFVUJDBM SFHVMBUJPOT

                         TFDA and National Pharmaceutical Regulatory Agency (NPRA) of Malaysia formally
                     VLJQHG WKH RI¿FLDO FROODERUDWLRQ GRFXPHQW RYHU SKDUPDFHXWLFDO UHJXODWLRQV RQ 0DUFK          LQ
                     .XDOD /XPSXU  0DOD\VLD   )LJXUH
                         There are five main aspects for the signed cooperation agreement for the management
                     of pharmaceutical products, including the exchange of related information to the management
                     of pharmaceutical products, the exchange of management technology, experience sharing of
                     management regulations, convention of regular meetings, and arrangement of personnel’s

                     exchange visits and seminars for the related pharmaceutical products.

                         )PMEJOH      5BJXBO "4&"/ ESVH SFHVMBUPSZ GPSVN

                         7KH ¿UVW       7DLZDQ $6($1 GUXJ UHJXODWRU\ IRUXP  KHOG E\ 7)'$ LQ      UHFHLYHG
                     great feedback from domestic and overseas experts, and thus we continue to hold the second
                     "2018 Taiwan-ASEAN drug regulatory forum".
                         The forum held a series of events on pharmaceutical administration issues from September

























                                         5'%" BOE /BUJPOBM 1IBSNBDFVUJDBM 3FHVMBUPSZ "HFODZ  /13"  PG
                              'JHVSF   cc
                                         .BMBZTJB GPSNBMMZ TJHOFE UIF PGGJDJBM DPMMBCPSBUJPO EPDVNFOU PWFS
                                         QIBSNBDFVUJDBM SFHVMBUJPOT                                        55
   52   53   54   55   56   57   58   59   60   61   62